Cheryl R Blanchard's Net Worth
$9.25 Million
Who is Cheryl R Blanchard?
Cheryl R Blanchard has an estimated net worth of $9.25 Million. This is based on reported shares across multiple companies, which include ZIMMER HOLDINGS INC, Vigil Neuroscience, Inc., SeaSpine Holdings Corp, Anika Therapeutics, Inc., Dare Bioscience, Inc., and Neuronetics, Inc..
SEC CIK
Cheryl R Blanchard's CIK is 0001326530
Past Insider Trading and Trends
2022 was Cheryl R Blanchard's most active year for acquiring shares with 9 total transactions. Cheryl R Blanchard's most active month to acquire stocks was the month of February. 2007 was Cheryl R Blanchard's most active year for disposing of shares, totalling 11 transactions. Cheryl R Blanchard's most active month to dispose stocks was the month of December. 2012 saw Cheryl R Blanchard paying a total of $474,360.00 for 62,716 shares, this is the most they've acquired in one year. In 2012 Cheryl R Blanchard cashed out on 33,372 shares for a total of $799,342.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIMMER HOLDINGS INC (ZBH) Snapshot price: $128.09
Sr. VP, Chief Scientific Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
| +19.69% | 3.02K |
$63.94 | -$86,191.12 | 18.36K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +14.41% | 1.93K |
$61.66 | -$53,150.92 | 15.34K |
Feb 17
| |||
Form 4
|
—
|
0
|
$47.27 | -$185,640.00 | 13.27K |
Scheduled
|
Jan 10
| ||
Form 4/A
| -6.15% | -862.00 |
$61.55 | -$53,056.10 | 13.15K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
$47.60 | -$139,240.00 | 13.12K |
Scheduled
|
Feb 18
| ||
Form 4
| +16.94% | 1.9K |
$61.55 | -$54,964.15 | 13.12K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +76.95% | 4.71K |
$59.33 | -$124,711.66 | 10.83K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +442.67% | 4.71K |
$39.05 | -$82,072.59 | 5.77K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -100.00% | -416.00 |
$85.67 | -$35,638.72 |
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$58.10 | -$334,860.00 | 764 |
Scheduled
|
Feb 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
$57.24 | -$736,867.60 | 764 |
Scheduled
|
Jan 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SeaSpine Holdings Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.08% | 8.86K |
—
|
—
| 28.95K |
May 30
| |||
Form 4
| +100.71% | 10.08K |
—
|
—
| 20.09K |
Jun 14
| |||
Form 4
|
∞
| 10.01K |
—
|
—
| 10.01K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anika Therapeutics, Inc. (ANIK) Snapshot price: $23.55
President, CEO, Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +31.69% | 36.5K |
$25.61 | -$716,629.18 | 151.69K |
Mar 11
| |||
Form 4
| +13.60% | 13.68K |
$26.34 | -$287,106.00 | 114.25K |
Apr 26
| |||
Form 4
| +20.12% | 16.85K |
$26.10 | -$344,807.10 | 100.58K |
Mar 10
| |||
Form 4
| +13.85% | 10.19K |
$26.91 | -$113,883.12 | 83.73K |
Mar 9
| |||
Form 4
| +50.93% | 24.58K |
—
|
—
| 72.83K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +15.61% | 8.1K |
$25.57 | $207,142.82 | 59.99K |
Mar 11
| |||
Form 4
| +38.48% | 14.42K |
—
|
—
| 51.89K |
Mar 9
| |||
Form 4
| +8.68% | 2.99K |
$33.40 | $99,999.60 | 37.47K |
Jun 15
| |||
Form 4
| +248.16% | 24.57K |
—
|
—
| 34.48K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +32.64% | 2.44K |
$33.40 | -$59,919.60 | 9.9K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +106.02% | 3.84K |
—
|
—
| 7.47K |
Feb 26
| |||
Form 4
|
∞
| 3.62K |
—
|
—
| 3.62K |
Aug 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dare Bioscience, Inc. (DARE) Snapshot price: $0.3302
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||